Literature DB >> 11257405

The potential of oligodeoxynucleotides as mucosal and parenteral adjuvants.

M J McCluskie1, R D Weeratna, H L Davis.   

Abstract

Synthetic oligodeoxynucleotides (ODN) containing immunostimulatory CpG motifs (CpG ODN) are potent adjuvants in mice when delivered by parenteral (intramuscular, subcutaneous) and mucosal (intranasal, oral and intrarectal) routes. We have recently shown that with mucosal delivery non-CpG ODN can also have immunostimulatory properties which, in contrast to the Th1-bias characteristic of CpG ODN, are predominantly Th2-like. Herein, using hepatitis B surface antigen (HBsAg) and tetanus toxoid (TT) as model antigens in BALB/c mice, we have examined a number of different ODN (CpG, non-CpG, poly-T, poly-CG) to determine their effects on immune responses after mucosal (oral) and parenteral (IM) immunizations. Our findings demonstrate that with mucosal delivery, there is a Th2-biased immunostimulatory effect that is associated with non-CpG ODN, and that the presence of CpG motifs can shift this towards a Th1 response. The adjuvant effect of non-CpG ODN was much less evident after parenteral immunization.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11257405     DOI: 10.1016/s0264-410x(00)00496-5

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  13 in total

1.  Enhancement of mucosal immunization with virus-like particles of simian immunodeficiency virus.

Authors:  Sang-Moo Kang; Richard W Compans
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

2.  Effective postexposure treatment of retrovirus-induced disease with immunostimulatory DNA containing CpG motifs.

Authors:  Anke R M Olbrich; Simone Schimmer; Klaus Heeg; Koen Schepers; Ton N M Schumacher; Ulf Dittmer
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

3.  Oligodeoxynucleotides lacking CpG dinucleotides mediate Toll-like receptor 9 dependent T helper type 2 biased immune stimulation.

Authors:  Jörg Vollmer; Risini D Weeratna; Marion Jurk; Ulrike Samulowitz; Michael J McCluskie; Paul Payette; Heather L Davis; Christian Schetter; Arthur M Krieg
Journal:  Immunology       Date:  2004-10       Impact factor: 7.397

4.  Mucosal delivery of bacterial antigens and CpG oligonucleotides formulated in biphasic lipid vesicles in pigs.

Authors:  Valeria Alcon; Maria Baca-Estrada; Marco Vega-Lopez; Philip Willson; Lorne A Babiuk; Praveen Kumar; Rolf Hecker; Marianna Foldvari
Journal:  AAPS J       Date:  2005-10-14       Impact factor: 4.009

5.  Immunogenicity and protective efficacy of a recombinant filamentous haemagglutinin from Bordetella pertussis.

Authors:  J B Knight; Y Y Huang; S A Halperin; R Anderson; A Morris; A Macmillan; T Jones; D S Burt; G Van Nest; S F Lee
Journal:  Clin Exp Immunol       Date:  2006-06       Impact factor: 4.330

6.  A CpG-containing oligodeoxynucleotide adjuvant for acellular pertussis vaccine improves the protective response against Bordetella pertussis.

Authors:  Catpagavalli Asokanathan; Michael Corbel; Dorothy Xing
Journal:  Hum Vaccin Immunother       Date:  2013-01-04       Impact factor: 3.452

7.  Mucosal immunization with liposome-nucleic acid adjuvants generates effective humoral and cellular immunity.

Authors:  Angela Henderson; Katie Propst; Ross Kedl; Steven Dow
Journal:  Vaccine       Date:  2011-05-19       Impact factor: 3.641

8.  Dietary deoxynucleic acid induces type 2 T-helper immune response through toll-like receptor 9 in mice.

Authors:  Mariko Nakamoto; Emi Shuto; Toshio Hosaka; Tohru Sakai
Journal:  Eur J Nutr       Date:  2010-12-04       Impact factor: 5.614

9.  Oral pretreatment of mice with CpG DNA reduces susceptibility to oral or intraperitoneal challenge with virulent Listeria monocytogenes.

Authors:  Nancy B Ray; Arthur M Krieg
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

10.  Enhanced antibody responses to a detoxified lipopolysaccharide-group B meningococcal outer membrane protein vaccine are due to synergistic engagement of Toll-like receptors.

Authors:  Wilbur H Chen; Subhendu Basu; Apurba K Bhattacharjee; Alan S Cross
Journal:  Innate Immun       Date:  2009-10-12       Impact factor: 2.680

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.